The role of chemotherapy for skull base carcinomas and sarcomas

Neurosurgery Clinics of North America

Volumn 11, Issue 4, 2000, Pages 681-691

  Adelstein, D J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOMA; HEAD CANCER; HUMAN; METASTASIS; NASOPHARYNX CARCINOMA; NECK CANCER; NEUROENDOCRINE TUMOR; PARAGANGLIOMA; PARANASAL SINUS CANCER; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND CANCER; SARCOMA; SKULL CANCER; SQUAMOUS CELL CARCINOMA;

EID: 0033735951     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1042-3680(18)30093-7     Document Type: Review

References (94)

1. The community approach to salvage therapy for advanced head and neck cancer
2. Treatment of head and neck cancer: The role of chemotherapy
3. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
4. Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland
5. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
6. Adjuvant therapy of sarcomas of soft tissue
7. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck
8. Malignant pheochromocytoma: Effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine
9. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): (1) Loco-regional treatment vs same treatment + chemotherapy (CT)
10. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
11. Combinationchemotherapy with vinblastine, bleomycin, and cisdiamminedichloroplatinum (II) in squamous cell carcinoma of the head and neck
12. Randomized study comparing radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma (ARCORO): Preliminary results of the 94.01 study from the French Group of Radiation Oncology for Head and Neck Cancer (GORTEC)
13. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma
14. The role of chemotherapy in the management of nasopharyngeal carcinoma
15. Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors
16. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
17. 0 disease
18. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck
19. Docetaxel in head and neck cancer: A review
20. Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancer
21. 0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival
22. Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients
23. Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer
24. Sinonasal undifferentiated carcinoma: A ray of hope
25. Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma
26. Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin
27. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck
28. Nasopharyngeal cancer: Epidemiology, staging, and treatment
29. Long term disease-free survivors in metastatic (MTS) undifferentiated carcinoma of nasopharyngeal type (UCNT)
30. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck
31. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group Study
32. Combined-modality therapy for head and neck cancer
33. Combined radiotherapy and chemotherapy with Neomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial
34. Undifferentiated carcinoma of the nose and paranasal sinuses
35. The role of adjuvant chemotherapy in the treatment of advanced head and neck cancer
36. Adjuvant and neoadjuvant treatment of head and neck cancers
37. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
38. Induction chemotherapy in advanced head and neck tumors: Results of two randomized trials
39. A randomized EORTC study on the effect of preoperative polychemotherapy in pyriform sinus carcinoma treated by pharyngolaryngectomy and irradiation. Results from 5 to 10 years
40. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5-fluorouracil as initial treatment of advanced laryngeal and hypopharyngeal squamous carcinoma
41. Chemotherapy for advanced sarcoma: Therapeutic decisions and modalities
42. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck
43. A randomized trial of cisplation (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck
44. Long term outcome in the treatment of stage III-IV head and neck (H/N) squamous cell carcinoma (SCCA) using supradose intra-arterial targeted cisplatin (SIT-P) and radiation therapy (RT)
45. Recurrent chondrosarcoma of the cranial base: A durable response to ifosfamide-doxorubicin chemotherapy
46. Multimodality therapy in advanced paranasal sinus carcinoma: Superior long-term results
47. Superselective intra-arterial chemotherapy of advanced paranasal sinus tumors
48. Larynx preservation in pyriform sinus cancer: Preliminary resuits of a European Organization for Research and Treatment of Cancer phase III trial
49. Adjuvant therapy for soft tissue sarcomas
50. A phase III randomized trial of cisplatinum, methotrexate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck
51. Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study
52. Chemotherapy for paranasal sinus carcinoma
53. Randomized study of 5-fluorouracil and cisplatin as neoadjuvant therapy in head and neck cancer: A preliminary report
54. Treatment of metastatic chemodectoma
55. Induction chemotherapy in head and neck cancer: Results of a phase III trial
56. Cisplatin and 5-fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of the head and neck
57. Malignant paraganglioma with skeletal metastases and spinal cord compression: Response and palliation with chemotherapy
58. The role of adjuvant chemotherapy in the treatment of adult soft tissue sarcomas
59. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo
60. A 15-year experience with chemotherapy of patients with paraganglioma
61. Chemotherapy for recurrent and metastatic head and neck cancer
62. Chemoradiation treatment strategies for localized sarcoma: Conventional and investigational approaches
63. Combination therapy of advanced head and neck cancer. Induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy
64. Sinonasal undifferentiated carcinoma: A 10 year experience
65. Targeted infusions of supradose cisplatin with systemic neutralization for carcinomas invading the temporal bone
66. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin
67. Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: An Eastern Cooperative Oncology Group pilot study
68. Multidisciplinary treatment of maxillary sinus carcinoma
69. Analysis of the results of combined therapy for maxillary carcinoma
70. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer
71. Combined bleomycin and radiotherapy in oral cancer
72. Reappraisal of trimodal combination therapy for maxillary sinus carcinoma
73. Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx
74. Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer: Preliminary report
75. Metastatic adenoid cystic carcinoma of salivary glands: Case reports and review of the literature
76. Management of malignant tumors of the salivary glands
77. Chemotherapy for metastatic soft tissue sarcomas
78. Combined modality therapy of head and neck cancer
79. Chemotherapy for adenocystic carcinoma
80. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinomas evaluated by computer tomography
81. Treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation
82. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data
83. Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer
84. 5-Fluorouracil, cyclophosphamide, and vincristine for adenoid cystic carcinoma of the head and neck
85. Systemic therapy of head and neck cancer: Most effective agents, areas of promise
86. Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: A phase II study of the EORTC Head and Neck Cancer Cooperative Group
87. A randomized prospective comparison of methotrexate and a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer
88. Head and neck cancer
89. Re-irradiation of recurrent nasopharyngeal carcinoma - Treatment technique and results
90. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer
91. Simultaneous chemoradiotherapy in the treatment of advanced head and neck cancer
92. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
93. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
94. Primary neuroendocrine carcinoma of head and neck: The University of Iowa experience